Literature DB >> 1988336

Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis.

S E Davies1, B C Portmann, J G O'Grady, P M Aldis, K Chaggar, G J Alexander, R Williams.   

Abstract

Long-term follow-up of 27 patients with hepatitis B virus-related chronic liver disease treated by transplantation showed that 23 had hepatitis B virus recurrence. In 13 patients late changes in the grafts were similar to those described in other series: minor abnormalities in five cases, chronic active hepatitis in five cases and non-hepatitis B virus-related graft dysfunction in three cases. Three patients had incomplete histological follow-up. Analysis of the histological changes and viral antigen expression in six cases revealed a distinct and novel pattern termed fibrosing cholestatic hepatitis. Development of fibrosing cholestatic hepatitis was associated with rapidly progressive graft dysfunction. It is postulated that this pattern of fibrosing cholestatic hepatitis develops because of a high cytoplasmic expression of viral antigens, including HBsAg. The remaining case had some features of fibrosing cholestatic hepatitis. The main histological features of this unique syndrome include thin, perisinusoidal bands of fibrosis extending from portal tracts to surround plates of ductular-type epithelium; prominent cholestasis; ground-glass transformation; and ballooning of hepatocytes with cell loss and mild mixed inflammatory reaction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988336

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  59 in total

1.  Long term outcome of liver transplantation for viral hepatitis: is there a need to re-evaluate patient selection?

Authors:  D Mutimer
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

2.  Significance testing of clinical data using virus dynamics models with a Markov chain Monte Carlo method: application to emergence of lamivudine-resistant hepatitis B virus.

Authors:  N J Burroughs; D Pillay; D Mutimer
Journal:  Proc Biol Sci       Date:  1999-12-07       Impact factor: 5.349

Review 3.  Management of hepatitis B in special populations.

Authors:  Kali Zhou; Norah Terrault
Journal:  Best Pract Res Clin Gastroenterol       Date:  2017-06-08       Impact factor: 3.043

Review 4.  Treatment of follicular non-Hodgkin's lymphoma.

Authors:  David G Maloney
Journal:  Curr Hematol Rep       Date:  2005-01

Review 5.  Hepatitis B virus infection in liver transplant candidates and recipients.

Authors:  Patrick Yachimski; Raymond T Chung
Journal:  MedGenMed       Date:  2005-04-18

Review 6.  Hepatology.

Authors:  P M Harrison; J Y Lau; R Williams
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

7.  Fibrosing cholestatic hepatitis in a kidney transplant recipient with hepatitis C virus.

Authors:  Takahiro Shinzato; Taro Kubo; Toshihiro Shimizu; Koji Nanmoku; Takashi Yagisawa
Journal:  CEN Case Rep       Date:  2019-01-02

Review 8.  Cholangiocyte proliferation and liver fibrosis.

Authors:  Shannon S Glaser; Eugenio Gaudio; Tim Miller; Domenico Alvaro; Gianfranco Alpini
Journal:  Expert Rev Mol Med       Date:  2009-02-25       Impact factor: 5.600

9.  Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus.

Authors:  Sílvia Vilarinho; Kouetsu Ogasawara; Stephen Nishimura; Lewis L Lanier; Jody L Baron
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-08       Impact factor: 11.205

10.  Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis.

Authors:  Yury Popov; Deanna Y Sverdlov; K Ramakrishnan Bhaskar; Anisha K Sharma; Gunda Millonig; Eleonora Patsenker; Stephan Krahenbuhl; Lukas Krahenbuhl; Detlef Schuppan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-01-07       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.